TBPH Theravance Biopharma, Inc.

bullish · high conviction track record →
Get emailed when TBPH changes direction
Mkt Cap $861M P/E 8.1 fwd 12.3 52wk $8.33 - $21.03 2h ago
Insider buying: $20,915,775 bought by 13 insiders (30d)
Est. revisions: +550.0% (1 up, 0 down in 30d)
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +3.0)

Factor Model

net +3.0
Est. Revisions
+1.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0

Insiders Buy $21M, Target Raised to $17

Watch: Upcoming quarterly earnings to validate sustained revenue growth and margin expansion.

Theravance Biopharma insiders led by Eli Samaha bought $20.9 million worth of shares at prices between $7.80 and $8.75. B. Riley raised the price target to $17 from $14 after TBPH secured a generic settlement extending exclusivity through April 2039. The company posted record Q4 non-GAAP profitability and achieved $75 million in milestone payments, supported by 12% growth in TRELEGY net sales.

Strong insider buying alongside a key patent settlement and favorable analyst upgrades signals growing confidence in TBPH's long-term revenue and profitability growth.

Evidence

4h ago Insider buy by SAMAHA ELI (TBPH): $13,117,335
4h ago Insider buy by SAMAHA ELI (TBPH): $7,798,440
7h ago RBC Capital Lifts PT on Incyte Corporation (INCY) to $95 From $92 yahoo-finance
Fundamentals & Data ▾
Theravance Biopharma, Inc. Healthcare · Biotechnology
Mkt Cap
$861M
P/E
8.1 fwd 12.3
Beta
0.17
52w Range
$8.33 - $21.03
Short Interest
5.3M 16.26%
Days to Cover
5.5 +11%
Insiders
buying 2B / 1S
EPS Estimate
$0.09 +550.0% 30d 1up / 0dn
Est. Dispersion
0% 1 analysts
Analyst Target
$17 $15 - $21
Options P/C
0.12
Insider Cluster
sell cluster 1B / 2S
Fund Convergence
strong Two Sigma, Citadel, D.E. Shaw
Financials
Revenue
$46M +145% YoY
FCF
$-6M
Op Margin
44%
Momentum: accelerating
Top Holders
Two Sigma $7M
Citadel $4M
D.E. Shaw $2M
Recent Filings & Data
insider trade 42
net buying · $3,897,528 sold · $20,915,775 bought
13 insiders · 42 transactions (30d)
Recent transactions
FARNUM RHONDA · award
SAWAF AZIZ · award
GRIMAUD BRETT A · award
WINNINGHAM RICK E · award
FARNUM RHONDA · sell · $433,637
FARNUM RHONDA · sell · $582,501
BROSHY ERAN · sell · $590,020
WINNINGHAM RICK E · other
BROSHY ERAN · sell · $1,068,250
BROSHY ERAN · sell · $809,250
BROSHY ERAN · exercise · $142,100
FARNUM RHONDA · sell · $113,870
WINNINGHAM RICK E · other
WINNINGHAM RICK E · other
FARNUM RHONDA · sell · $264,000
GRAY SUSANNAH · award
GRANT JEREMY T · award
MILLER AINE · award
BROSHY ERAN · award
MITCHELL DEAN J · award
PAKIANATHAN DEEPIKA R · award
SMALDONE ALSUP LAURIE · award
O'CONNOR DONAL · award
FARNUM RHONDA · sell · $36,000
FARNUM RHONDA · award
SAWAF AZIZ · award
GRIMAUD BRETT A · award
MILLER AINE · award
WINNINGHAM RICK E · award · $20,364
FARNUM RHONDA · award
WINNINGHAM RICK E · award · $30,557
SAMAHA ELI · buy · $7,798,440
WINNINGHAM RICK E · award · $25,463
WINNINGHAM RICK E · award · $20,370
GRAY SUSANNAH · award
GRANT JEREMY T · award
BROSHY ERAN · award
MITCHELL DEAN J · award
PAKIANATHAN DEEPIKA R · award
SMALDONE ALSUP LAURIE · award
O'CONNOR DONAL · award
SAMAHA ELI · buy · $13,117,335
3 signals · latest 4h ago

Get alerted when TBPH changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →